Zobrazeno 1 - 10 of 170 pro vyhledávání: '"John C. LaRosa"'
1
Akademický článek
Comparison of the triglyceride lipase of liver, adipose tissue, and postheparin plasma
Autor: John C. LaRosa, Robert I. Levy, Herbert G. Windmueller, Donald S. Fredrickson
Publikováno v: Journal of Lipid Research, Vol 13, Iss 3, Pp 356-363 (1972)
Heparin-released triglyceride lipase from three sources, adipose tissue, liver, and postheparin plasma, was compared. Heparin-released triglyceride lipase from liver differed in several major respects from that in adipose tissue. These differences in
Externí odkaz: https://doaj.org/article/85f1552c049549fe989759088888db9f
Zobrazit plný text záznamu
2
Akademický článek
Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers.
Autor: Benoit J Arsenault, Philip Barter, David A DeMicco, Weihang Bao, Gregory M Preston, John C LaRosa, Scott M Grundy, Prakash Deedwania, Heiner Greten, Nanette K Wenger, James Shepherd, David D Waters, John J P Kastelein, Treating to New Targets (TNT) Investigators
Publikováno v: PLoS ONE, Vol 9, Iss 12, p e114519 (2014)
Several plasma non-lipid biomarkers have been shown to predict major cardiovascular events (MCVEs) in population studies. Our objective was to investigate the relationship between lipid and non-lipid biomarkers levels achieved during statin therapy a
Externí odkaz: https://doaj.org/article/9b5a5887723d480fad24e9e88d562e78
Zobrazit plný text záznamu
3
Estimated individual lifetime benefit from PCSK9 inhibition in statin-treated patients with coronary artery disease
Autor: Kausik K. Ray, Lotte Kaasenbrood, S. Matthijs Boekholdt, Yvo M. Smulders, John C. LaRosa, John J.P. Kastelein, Frank L.J. Visseren, Jannick A N Dorresteijn, Yolanda van der Graaf
Publikováno v: Heart (British Cardiac Society), 104(20), 1699-1705. BMJ Publishing Group
Heart, 104(20), 1699. BMJ Publishing Group
Heart, 104(20), 1699-1705. BMJ Publishing Group
Kaasenbrood, L, Ray, K K, Boekholdt, S M, Smulders, Y M, LaRosa, J C, Kastelein, J J P, van der Graaf, Y, Dorresteijn, J A N & Visseren, F L J 2018, ' Estimated individual lifetime benefit from PCSK9 inhibition in statin-treated patients with coronary artery disease ', Heart, vol. 104, no. 20, pp. 1699-1705 . https://doi.org/10.1136/heartjnl-2017-312510
ObjectiveIn statin-treated patients with stable coronary artery disease (CAD), residual risk of cardiovascular events is partly explained by plasma levels of low-density lipoprotein cholesterol (LDL-C). This study aimed to estimate individual benefit
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13b7d5896e9638a4559e5651bc63ad09
https://doi.org/10.1136/heartjnl-2017-312510
Zobrazit plný text záznamu
4
Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention Population
Autor: Gert J. de Borst, Jan Westerink, Pierre Amarenco, John J.P. Kastelein, Lotte Kaasenbrood, Frank L.J. Visseren, S. Matthijs Boekholdt, Maarten J. Cramer, John C. LaRosa, Kausik K. Ray, L. Jaap Kappelle, Yolanda van der Graaf, Ron J.G. Peters
Publikováno v: Circulation, 134(19), 1419-1429. Lippincott Williams and Wilkins
Circulation, 134(19), 1419. Lippincott Williams and Wilkins
Background: Among patients with clinically manifest vascular disease, the risk of recurrent vascular events is likely to vary. We assessed the distribution of estimated 10-year risk of recurrent vascular events in a secondary prevention population. W
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7dfe99ab5f28af6f62ed85dce9c19ad
https://doi.org/10.1161/circulationaha.116.021314
Zobrazit plný text záznamu
5
Differences in Risk Factor Profile between Carotid Intimal Medial Thickness and Pulse Wave Velocity in African-Americans with Type 2 Diabetes
Autor: Ahmed Bakillah, Louis Salciccioli, Fasika Tedla, Ajibola M. Adedayo, Clinton D. Brown, Nicole Mastrogiovanni, Arye Kremer, Ayobami Eluwole, Mary Ann Banerji, Jason Lazar, Moro O. Salifu, Paul Dreizen, Mohamed Boutjdir, John C. LaRosa, Carl Rosenberg
Publikováno v: Diabetes. 67
Background: Diabetes is a robust risk factor for cardiovascular events which is marked in African Americans for reasons that may be attributed to socioeconomic and biologic vulnerabilities. Both structural (arterial thickening) and functional (arteri
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1ce148e888541f5a636c7ed166e88664
https://doi.org/10.2337/db18-1597-p
Zobrazit plný text záznamu
6
Relationship between Nitrated High-Density Lipoproteins and Vascular Function in African-American Diabetic Patients
Autor: Nicole Mastrogiovanni, Ahmed Bakillah, Jason Lazar, Clinton D. Brown, Louis Salciccioli, Carl Rosenberg, Arye Kremer, Fasika Tedla, Ajibola M. Adedayo, Moro O. Salifu, Mary Ann Banerji, Ayobami Eluwole, Paul Dreizen, Mohamed Boutjdir, John C. LaRosa
Publikováno v: Diabetes. 67
Previous studies have shown that HDL isolated from human atherosclerotic lesions and the blood of patients with established coronary artery disease contains elevated levels of nitrated apolipoprotein AI (NT-apoAI). The significance of NT-apoAI in the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::84be1d726fb22a5a6eab36dfd7e21756
https://doi.org/10.2337/db18-611-p
Zobrazit plný text záznamu
7
A Comparative Study of the Associations between Modified Low-Density Lipoproteins and Vascular Function in African-American Diabetic Patients
Autor: Ahmed Bakillah, Louis Salciccioli, John C. LaRosa, Arye Kremer, Ayobami Eluwole, Nicole Mastrogiovanni, Paul Dreizen, Clinton D. Brown, Mohamed Boutjdir, Moro O. Salifu, Carl Rosenberg, Mary Ann Banerji, Fasika Tedla, Ajibola M. Adedayo, Jason Lazar
Publikováno v: Diabetes. 67
Background: LDL plays a key role in development and progression of atherosclerosis. Elevated LDL amplifies the atherosclerotic process but the significance of modified LDL in pathogenesis of vascular complications is unclear. We aimed to assess plasm
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ea884868c3caaa10ff84d54f9d315fa3
https://doi.org/10.2337/db18-468-p
Zobrazit plný text záznamu
8
RELATIONSHIP BETWEEN SOLUBLE F11 RECEPTOR, TOTAL NITRIC OXIDE LEVELS, AND VASCULAR FUNCTION IN AFRICAN AMERICANS WITH TYPE II DIABETES
Autor: Louis Salciccioli, Mohamed Boutdjir, Arye Kremer, Mary Ann Banerji, Ayobami Eluwole, Fasika Tedla, Ajibola M. Adedayo, Ahmed Bakillah, Clinton D. Brown, Carl Rosenberg, Jason Lazar, Muhammad Khan, Moro O. Salifu, Nicole Mastrogiovanni, Paul Dreizen, John C. LaRosa
Publikováno v: Journal of the American College of Cardiology. 73:2076
Human F11 receptor (F11R) is an important cell adhesion molecule implicated in inflammatory thrombosis. F11R is associated with the presence and severity of cardiovascular disease. Endothelial dysfunction in diabetes has been attributed to lack of bi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f836c1d4853654b0764472cee97780a7
https://doi.org/10.1016/s0735-1097(19)32682-8
Zobrazit plný text záznamu
10
RETRACTED: Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease [Am Heart J 2012;164:387-393]
Autor: David D. Waters, Michael Messig, Vera Bittner, David A. DeMicco, Nanette K. Wenger, John C. LaRosa
Publikováno v: American Heart Journal. 164:387-393
BACKGROUND This post hoc nested case-control analysis of the TNT study was designed to investigate whether baseline vitamin D level is a significant predictor of cardiovascular risk among statin-treated patients and whether changes in vitamin D after
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d2e15efd1802c129ef452af0b737d4f8
https://doi.org/10.1016/j.ahj.2012.06.016
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje